Mouse Anti-CEACAM19 Recombinant Antibody (Z5P2D9/A9) (CBMAB-C1207-CQ)

Zisi, Z., Adamopoulos, P. G., Kontos, C. K., & Scorilas, A. (2020). Identification and expression analysis of novel splice variants of the human carcinoembryonic antigen-related cell adhesion molecule 19 (CEACAM19) gene using a high-throughput sequencing approach. Genomics, 112(6), 4268-4276.

Tsouraki, D., & Kontos, C. K. (2020). CEACAM19 (carcinoembryonic antigen related cell adhesion molecule 19). Atlas of Genetics and Cytogenetics in Oncology and Haematology.

Hu, X., Chen, M., Li, Y., Wang, Y., Wen, S., & Jun, F. (2019). Aberrant CEACAM19 expression is associated with metastatic phenotype in penile cancer. Cancer management and research, 11, 715.

Zhao, H., Xu, J., Wang, Y., Jiang, R., Li, X., Zhang, L., & Che, Y. (2018). Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB. Surgical oncology, 27(3), 495-502.

Estiar, M. A., Esmaeili, R., Zare, A. A., Farahmand, L., Fazilaty, H., Zekri, A., ... & Majidzadeh-a, K. (2017). High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer. Clinical and experimental medicine, 17(4), 547-553.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Recombinant Mouse Anti-CEACAM19 Recombinant Antibody (Z5P2D9)

Mouse Anti-CEACAM19 Recombinant Antibody (A9)

Isotype control